UK Study Questions Robot Surgery's Value

Large-scale studies conducted in the UK have revealed that robot-assisted hip and knee replacement surgeries do not yield better results than traditional methods. The research, which examined data from 666,283 hip replacements and 697,145 knee replacements between 2018 and 2024, found no discernible difference in patient outcomes.

These analyses, which meticulously matched patients based on various health and surgical factors, indicate similar implant survival rates, revision risks, and complication occurrences over an average follow-up period of 2.5 years. Patient survival post-hip replacement also showed no variation between robotic and conventional procedures.

Despite earlier suggestions that robotic systems improve implant placement, the recent findings challenge the clinical benefit of this precision. The substantial upfront costs of approximately £1 million for robotic systems, plus additional per-patient expenses ranging from £1,000 to £2,500, are now being scrutinized against these comparable outcomes.

These results cast doubt on future expansion plans, such as the NHS's intention to sevenfold its robotic surgery capacity by 2035. Medical professionals, including those at the All India Institute of Medical Sciences (AIIMS), have noted that the perceived advantages of robot-assisted surgery may have been overstated, potentially driven by corporate interests linked to implant manufacturers.

While the studies are observational and cannot definitively establish causation, they highlight the need for further urgent research, as called for by the National Institute for Health and Care Excellence. The rapid spread of robotic joint replacement in India's private sector over the past decade also prompts a re-evaluation of its efficacy and value proposition.